Key facts
- Affect’s last known valuation is $58.1M (Jul 2023).
- It has raised $52.1M; the latest was Later Stage VC ($26.0M) in Jan 2025.
- Notable investors include Mana Ventures, Gaingels, National Institutes of Health, Samsung NEXT Ventures, AlleyCorp — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Affect
- ·The full record, as it builds
Funding rounds
No funding rounds for Affect are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Affect
Developer of a digital treatment platform intended for mental health and addiction care. The company's platform delivers counseling, prescribing, peer support, daily challenges, medication-assisted treatment, and a contingency-management rewards system through a secure smartphone app, enabling patients to access evidence-based, science-backed behavioral health support with high accessibility and reduced barriers.
- Sector
- Healthcare
- HQ
- McLean, VA, United States
- Founded
- 2020
- Employees
- 122
- Website
- affect.com/
- Ownership
- Privately Held (backing)
Affect doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Affect shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Affect in its N-PORT filings yet. We sweep new filings monthly.